| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/12/2002 | WO2002070731A2 Methods and primers for evaluating hiv-1 mutations |
| 09/12/2002 | WO2002070730A2 Models and methods for determining systemic properties of regulated reaction networks |
| 09/12/2002 | WO2002070729A2 Improved skin substitutes and uses thereof |
| 09/12/2002 | WO2002070725A1 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 09/12/2002 | WO2002070723A2 Maize peroxidase genes and their use for improving plant disease resistance and stalk strength |
| 09/12/2002 | WO2002070722A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/12/2002 | WO2002070721A2 Recombinant dimorphic fungal cell |
| 09/12/2002 | WO2002070720A1 Cloning vectors and method for molecular cloning |
| 09/12/2002 | WO2002070719A2 Regulatable gene expression system |
| 09/12/2002 | WO2002070718A1 Dna encoding l-ribose isomerae and use thereof |
| 09/12/2002 | WO2002070717A2 Nitrile hydratase and a method for producing amides |
| 09/12/2002 | WO2002070716A1 Allergen ole e 9 from olea europaea, recombinant dna coding for said allergen, the production and use thereof |
| 09/12/2002 | WO2002070715A1 Human g-type lysozyme, the encoding sequence, preparing method and the uses thereof |
| 09/12/2002 | WO2002070714A1 Aminoketone asymmetric reductase and nucleic acid thereof |
| 09/12/2002 | WO2002070713A2 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins |
| 09/12/2002 | WO2002070712A2 Chitin deacetylase and method for producing the same |
| 09/12/2002 | WO2002070711A1 Vaccine |
| 09/12/2002 | WO2002070710A1 Method to identify ires elements |
| 09/12/2002 | WO2002070709A2 Molecules for disease detection and treatment |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070707A2 Novel gpcr-like proteins and nucleic acids encoding same |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070705A2 Human 7tm proteins and polynucleotides encoding them |
| 09/12/2002 | WO2002070704A2 Adipocyte complement related protein zacrp11 |
| 09/12/2002 | WO2002070703A2 Cell visual characteristic-modifying sequences |
| 09/12/2002 | WO2002070702A2 Polypeptides capable of interacting with smad polypeptide |
| 09/12/2002 | WO2002070701A2 Novel human gnrh receptor |
| 09/12/2002 | WO2002070700A1 Polynucleotide useful for modulating cancer cell proliferation |
| 09/12/2002 | WO2002070699A2 Cofactors of the estrogen receptor alpha and methods of use |
| 09/12/2002 | WO2002070698A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 09/12/2002 | WO2002070697A1 Mammalian nuclear receptor l67 and methods of use |
| 09/12/2002 | WO2002070696A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 09/12/2002 | WO2002070695A2 Tumor associated proteins |
| 09/12/2002 | WO2002070694A2 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell |
| 09/12/2002 | WO2002070693A2 Novel abca6 transporter and uses thereof |
| 09/12/2002 | WO2002070692A2 Abca9 transporter and uses thereof |
| 09/12/2002 | WO2002070691A2 Abcg4 transporter and uses thereof |
| 09/12/2002 | WO2002070690A2 Abca5 transporter and uses thereof |
| 09/12/2002 | WO2002070689A1 Method of extracting virus gene and extraction apparatus |
| 09/12/2002 | WO2002070688A1 Novel protein and dna encoding the same |
| 09/12/2002 | WO2002070687A1 Highly sensitive nucleic acid hybridization method and gene analysis method by using the same |
| 09/12/2002 | WO2002070685A2 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene |
| 09/12/2002 | WO2002070684A2 Gene library for screening methods |
| 09/12/2002 | WO2002070681A1 Protein c variants |
| 09/12/2002 | WO2002070680A1 Method of identifying inhibitors of cdc25 |
| 09/12/2002 | WO2002070676A2 Use of protein histidine phosphatase |
| 09/12/2002 | WO2002070673A1 Concentration and lysis of adenovirus-infected cells in a single unit operations |
| 09/12/2002 | WO2002070672A2 Plant cell having animal-type sugar chain adding function |
| 09/12/2002 | WO2002070670A1 Novel lactobacillus reuteri useful as probiotics |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070667A2 High level insect expression of rage proteins |
| 09/12/2002 | WO2002070665A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | WO2002070664A2 Method for rapid detection and identification of bioagents |
| 09/12/2002 | WO2002070662A2 Three hybrid assay system |
| 09/12/2002 | WO2002070661A2 Identification and characterization of a waxy curled leaf phenotype (wcl1) in arabidopsis |
| 09/12/2002 | WO2002070658A2 Compositions and methods for increasing amino acid absorption in mammals |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070651A2 Viral reporter particles |
| 09/12/2002 | WO2002070650A2 Dynamic whole genome screening methodology and systems |
| 09/12/2002 | WO2002070648A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 09/12/2002 | WO2002070647A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 09/12/2002 | WO2002070645A2 Functional surface display of polypeptides |
| 09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
| 09/12/2002 | WO2002070564A2 The guinea pig proteinase-activated receptor 4 and its activating peptide |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070554A2 Dna encoding human cid2 |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | WO2002070548A2 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/12/2002 | WO2002070542A2 Band 3 antigenic peptides, malaria polypeptides and uses thereof |
| 09/12/2002 | WO2002070536A1 Antisense modulation of recql2 expression |
| 09/12/2002 | WO2002070535A1 Antisense modulation of recql5 expression |
| 09/12/2002 | WO2002070007A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | WO2002070005A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | WO2002070003A1 Altered peptide ligands |
| 09/12/2002 | WO2002070002A2 Methods for regulation of immune responses to conditions involving mediator-induced pathology |
| 09/12/2002 | WO2002069997A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | WO2002069991A1 Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 09/12/2002 | WO2002069947A2 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer |
| 09/12/2002 | WO2002069908A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 09/12/2002 | WO2002069903A2 Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002069840A2 Nucleic acids for transforming fish cells and methods for their use |
| 09/12/2002 | WO2002069799A1 Method of predicting stroke evolution utilising mri |
| 09/12/2002 | WO2002063010A9 Method of producing recombinant antibodies against tumors |
| 09/12/2002 | WO2002062851A8 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 09/12/2002 | WO2002057409A3 Antisense modulation of src-2 expression |
| 09/12/2002 | WO2002052012A3 Sugar beet genes involved in stress tolerance |
| 09/12/2002 | WO2002049576A3 Fab i and inhibition of apicomplexan parasites |
| 09/12/2002 | WO2002042477A3 Process for increasing the level of sterols in plants |
| 09/12/2002 | WO2002033067A3 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis |